Position in VERA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$136,710,551
-$37,139,151 QoQ
Shares Held
3,398,224
-1.0% QoQ
Ownership
4.73%
of shares outstanding
% of Portfolio
8.68%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Kynam Capital Management, LP holds $1,494,846,229 across 33 Biotechnology names. VERA ranks #5 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SNDX |
Syndax Pharmaceuticals Inc
|
8,050,959 | $188,070,402 | |
| 2 | CLDX |
Celldex Therapeutics, Inc.
|
5,840,567 | $185,262,785 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
2,922,335 | $169,816,886 | |
| 4 | COGT |
Cogent Biosciences, Inc.
|
4,037,331 | $155,396,870 | |
| 5 | VERA |
Vera Therapeutics, Inc.
This page
|
3,398,224 | $136,710,551 | |
| 6 | BEAM |
Beam Therapeutics Inc.
|
3,682,185 | $87,746,468 | |
| 7 | CTMX |
CytomX Therapeutics, Inc.
|
15,013,093 | $70,561,537 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
1,569,018 | $46,615,524 |
All Filings in VERA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $136,710,551 | 3,398,224 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $173,849,702 | 3,433,051 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $117,047,868 | 4,027,800 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $80,737,457 | 3,426,887 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $80,737,457 | 3,426,887 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $57,648,000 | 2,400,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $61,655,013 | 1,457,910 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $69,683,465 | 1,576,549 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $55,849,944 | 1,543,669 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $65,835,055 | 1,526,787 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $56,142,213 | 3,650,339 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $40,527,486 | 2,956,053 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $48,150,000 | 3,000,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $26,170,041 | 3,372,428 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $27,266,046 | 1,409,098 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $32,736,017 | 1,536,181 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,724,110 | 1,522,712 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,799,684 | 502,328 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $6,772,157 | 253,449 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||